937.7500 -9.55 (-1.01%)
NSE Sep 09, 2025 15:31 PM
Volume: 73,236
 

ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues increased 18% YoY to | 741 crore (I-direct estimate: | 783 crore) on account of 54% YoY growth in the US to | 200 crore. Domestic formulations grew 10% YoY to | 286 crore (I-direct estimates: | 304 crore) driven by 13% growth in speciality portfolio EBITDA margins contracted 471 bps YoY to 18.2% (I-direct estimate: 19.2%) due to higher raw material and employee cost. EBITDA declined 6% YoY to | 135 crore (I-direct estimate: | 151 crore)...
Alembic Pharmaceuticals Ltd. is trading below all available SMAs
More from Alembic Pharmaceuticals Ltd.
Recommended